Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 13, No 3 (2020) Evaluation of the antitumor drugs therapeutic value using the method of multicriterial analysis of decision-making Abstract  similar documents
V. A. Lemeshko, N. Z. Musina, V. V. Omelyanovskiy
"... Aim. Development of a tool for the evaluation of the therapeutic value of anticancer drugs based ..."
 
Vol 10, No 2 (2017) THE USE OF MULTI-CRITERIAL DECISION ANALYSIS (MCDA) FOR ESTIMATING THE THERAPEUTIC VALUE OF INNOVATIVE DRUGS Abstract  similar documents
V. K. Fedyaeva, V. V. Omelyanovskiy, N. Z. Musina, G. R. Khachatryan, O. I. Ivakhnenko
"... , especially of innovative medicines. In many countries, the “therapeutic value” of a medicine is commonly used ..."
 
Vol 10, No 3 (2017) Review of the current approaches to the assessment of the drug innovative potential worldwide Abstract  similar documents
N. Z. Musina, V. K. Fedyaeva, V. V. Omel’yanovskii, G. R. Khachatryan, K. V. Gerasimova, V. A. Lemeshko, K. P. Konchits
"... A set of criteria for assessing the innovative potential of drugs (therapeutic value) have been ..."
 
Vol 10, No 4 (2017) IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET Abstract  similar documents
V. A. Lemeshko, N. Z. Musina, V. K. Fedyaeva
"... the therapeutic value of the drug into its consumer price. The drug pricing system existing in the Russian ..."
 
Vol 11, No 3 (2018) Economic barriers restraining the production of therapeutic recombinant human trypsin. Use of innovative technologies to overcome them Abstract  similar documents
S. V. Ponomarenko
"... human trypsin is proposed to be an innovative, safe and effective therapeutic protease. However ..."
 
Vol 6, No 2 (2013) PHARMACOECONOMIC MODELING OF ANTIRETROVIRAL DRUGS USE DURING TREATMENT OF HIV INFECTION Abstract  similar documents
V. A. Chibilyaev, A. Yu. Kulikov, R. I. Yagudina
"... Comparative pharmacoeconomic analysis of two therapeutic strategy (the strategy A and the strategy ..."
 
Vol 11, No 1 (2018) Medical care of ambulatory patients and its assessment: a review of international experience Abstract  similar documents
D. V. Lukyantseva, O. A. Sukhorukikh, V. V. Omelyanovsky
"... риски разработки и применения  критериев оценки качества в различных зарубежных странах. ..."
 
Vol 6, No 3 (2013) ECONOMIC EVALUATION OF THE EFFECTIVENESS OF LOW MOLECULAR WEIGHT HEPARIN AND INTERMITTENT PNEUMATIC COMPRESSION IN WOMEN IN A CYCLE OF IN VITRO FERTILIZATION Abstract  similar documents
A. P. Momot, I. V. Molchanova, N. A. Semenova, O. P. Tomilina, E. A. Elykomov, O. G. Borisova
"... that the conduction of therapeutic correction of excessive thrombin generation and / or hypofibrinolysis in patients ..."
 
Vol 12, No 3 (2019) Availability and Pharmacoeconomics of Insulin Therapy in Countries with the Largest Number of Diabetics Abstract  PDF (Eng)  similar documents
S. V. Ponomarenko
"... and economic importance of insulin therapy and industrial production of therapeutic recombinant insulin ..."
 
Vol 5, No 2 (2012) METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES Abstract  similar documents
R. I. Yagudina, I. V. Sorokovikov
"... . The results of analysisis CUR coefficient (ICUR), reflecting cost value on utility unit. Correct assessment ..."
 
Vol 11, No 4 (2018) International experience in determining the cost-effectiveness thresholds Abstract  similar documents
T. P. Bezdenezhnykh, N. Z. Musina, V. K. Fedyaeva, T. S. Tepcova, V. A. Lemeshko, V. V. Omelyanovsky
"... -to-pay threshold (WTP), the threshold value of the incremental cost-effectiveness ratio (ICeR), in europe ..."
 
Vol 6, No 4 (2013) Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention of the venous tromboembolism in the conditions of multidisciplinary hospital Abstract  similar documents
A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina
"... strategy in surgical and therapeutic patients. The additional model included the patient with signigicant ..."
 
Vol 12, No 4 (2019) Developing clinical guidelines and assessing the quality of medical care using the RAND/UCLA method Abstract  similar documents
O. O. Buzuverova, V. K. Fedyaeva, O. A. Sukhorukikh
"... рекомендаций, разработки критериев оценки качества медицинской помощи, для оценки приемлемости проведения ..."
 
Vol 10, No 2 (2017) COST-EFFECTIVENESS OF VILANEROL / UMECLIDINIUM VERSUS TIOTROPIUM IN SEVERE AND VERY SEVERE COPD Abstract  similar documents
E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov
"... of management of adverse events and/or COPD exacerbations were calculated. The costs of these two therapeutic ..."
 
Vol 10, No 2 (2017) CLINICAL AND ECONOMIC EVALUATION OF CHRONIC DISEASE TREATMENT: A DISCREPANCY BETWEEN THE TRADITIONAL PHARMACOECONOMIC AND SOCIO-ECONOMIC ANALYSES Abstract  similar documents
O. V. Zhukova, S. V. Kononova
"... -effectiveness” method) and socio-economic analysis of pharmaco-therapeutic regimens in a chronic disease ..."
 
Vol 6, No 3 (2013) THE ANALYSIS OF THE MARKET OF PHARMACEUTICALS FOR DYSMENORRHEA TREATMENT Abstract  similar documents
N. Yu. Cherkasova, A. V. Fomina, O. V. Filippova
"... medicines have quite extensive list of the registered therapeutic indications that complicates the analysis ..."
 
Vol 6, No 3 (2013) METHODOLOGICAL BASIS OF STANDARD GAMBLE METHOD USAGE IN QUALITY OF LIFE ASSESSMENT IN PHARMACOECONOMIC RESEARCHES Abstract  similar documents
R. I. Yagudina, A. Ju. Kulikov, D. T. Ugrekhelidze
"... of research using props, as well as computer programs that calculate the values of the utility automatically ..."
 
Vol 12, No 1 (2019) Individual cost accounting in the management of medical organizations Abstract  similar documents
I. A. Zheleznyakova, L. A. Kovaleva, T. A. Khelisupali
"... of costs to charges (RCC); relative value unit (RVU); time-driven activity-based costing (TDABC ..."
 
Vol 6, No 4 (2013) Фармакоэкономический анализ использования лираглутида в составе комбинированной терапии в лечении сахарного диабета 2-го типа Abstract  similar documents
A. Yu. Kulikov, I. V. Novikov
"... ), body mass index and blood pressure are extracted. Utility values are mostly taken from the UK ..."
 
Vol 10, No 3 (2017) Initiation and intensification of insulin therapy in patients with type 2 diabetes mellitus: a budget impact analysis Abstract  similar documents
E. V. Biryukova, V. I. Ignat’eva
"... use, all these regimens have the similar efficacy and safety; therefore, when choosing a therapeutic ..."
 
Vol 5, No 2 (2012) MEDICO-ECONOMIC SUBSTANTIATION OF NORMATIVE STANDARD OF SUPPLYING STUDENTS OF MILITARY SCHOOLS WITH MEDICATIONS Abstract  similar documents
Yu. V. Miroshnichenko, V. S. Gaynov
"... , устанавливающего норму снабжения лекарственными препаратами и материалами для терапевтической стоматологии ..."
 
Vol 6, No 4 (2013) Using indirect comparisons in pharmacoeconomic examination Abstract  similar documents
Yu. E. Balykina, A. S. Kolbin
"... , but in its comparison with similar therapeutic approaches. The above is the essence of a comparative study ..."
 
Vol 6, No 1 (2013) THE FEATURES OF METHODOLOGY FOR PHARMACOECONOMICS ANALYSIS OF VACCINATION Abstract  similar documents
A. Yu. Kulikov, Yu. L. Akimova
"... вакцинопрофилактики. Приведены критерии выбора показателей эффективности для различных типов вакцин, расчеты затрат на ..."
 
Vol 5, No 3 (2012) DEVELOPMENT OF A COMPUTER MODULE FOR FORECASTING AND ESTIMATING EFFICIENCY OF BASIC THERAPY OF MULTIPLE SCLEROSIS Abstract  similar documents
F. A. Khabirov, D. Kh. Shakirova, O. A. Dun, T. I. Khaibullin
"... базисной терапии рассеянного склероза. Отобраны критерии эффективности иммуномодулирующей терапии ..."
 
Vol 10, No 2 (2017) COSTS OF ANTIRETROVIRAL DRUGS USED IN THE THERAPY OF HIV-INFECTED PATIENTS: A PHARMACOECONOMIC ANALYSIS Abstract  similar documents
M. B. Kubaeva, Y. Sh. Guchshina
"... The aim of our study was to conduct a pharmacoeconomic and cost analysis of the therapeutic use ..."
 
Vol 10, No 1 (2017) THE USE OF QALY AS AN INTEGRAL MEASURE OF EFFECTIVENESS IN THE EVALUATION OF MEDICAL TECHNOLOGIES Abstract  similar documents
N. Z. Musina, V. K. Fedyaeva
"... критерий эффективности при проведении оценки технологий здравоохранения. Его универсальность позволяет ..."
 
Vol 7, No 1 (2014) EVALUATION OF SAFETY OF DRUG THERAPY IN CLINICAL PRACTICE Abstract  similar documents
M. N. Kostyleva, Yu. B. Belousov, A. N. Gratsianskaya, S. S. Postnikov
"... критерии определения, методы сбора (их преимущества и недостатки), учета и анализа нежелательных явлений ..."
 
Vol 9, No 4 (2016) REVIEW OF PRACTICE AND POSSIBLE DIRECTIONS OF CONCRETIZATION THE PROGRAM OF STATE GUARANTEES FОR FREE MEDICAL CARE FOR RUSSIAN CITIZENS Abstract  similar documents
D. V. Fedyaev, L. S. Melnikova, V. I. Ignatyeva
"... . Предложены основные направления конкретизации, критерии проведения конкретизации для отдельных видов ..."
 
Vol 11, No 2 (2018) Regional adaptation of the federal model of reimbursement for medical assistance based on clinical statistical groups: hospitalization of patients in need of genetically enginered biological preparations Abstract  similar documents
M. V. Sura, T. N. Ignatova, N. S. Rudneva, Yu. N. Sukhanova, N. G. Ulyanova, A. S. Khudyaev, V. A. Shelyakin, D. V. Scherbakov
"... to the therapeutic use of GiBP. The models of such specific CSGs proposed by RF subjects (after an expert evaluation ..."
 
Vol 11, No 2 (2018) Comments to the article by O. Yu. Rebrova and co-authors «Screening at the first stage of periodical health checkup: a systematic review of long-term results» Abstract  similar documents
V. A. Aksenov
"... , Medline/PubMed, USPSTF. Изучаемый тип публикаций – систематические обзоры. Критерии эффективности ..."
 
Vol 11, No 2 (2018) Implementation of the Federal Law «On Protection of Consumer Rights» in the provision of paid medical services: recommendations on signing the contract Abstract  similar documents
M. A. Amkhadova, E. V. Batler, D. G. Ilyuhin, I. A. Petrova
"... платных медицинских услуг, а также критерии своевременности оказания платной медицинской услуги ..."
 
Vol 7, No 3 (2014) PHARMACOEPIDEMIOLOGY OF ORIGINAL DROTAVERINE USE IN DYSMENORRHEA: RESULTS OF AN INTERNATIONAL MULTICENTER STUDY Abstract  similar documents
A. L. Unanyan, V. A. Alimov, S. E. Arakelov, M. S. Afanasyev, D. V. Baburin, D. V. Blinov, T. D. Guriyev, U. V. Zimovina, A. E. Kadyrova, Yu. M. Kossovich, L. S. Polonskaya
"... visits), non-interventional on the therapeutic strategy was conducted in Mexico, Kazakhstan, and Russia ..."
 
Vol 6, No 2 (2013) COST-EFFECTIVENESS ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS Abstract  similar documents
R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov
"... использованием в качестве критериев эффективности значений достижения большого молекулярного ответа (БМО) и ..."
 
Vol 8, No 1 (2015) SOCIAL AND ECONOMIC BURDEN OF FIVE NATURAL FOCAL INFECTIONS IN THE RUSSIAN FEDERATION Abstract  similar documents
A. E. Platonov, N. A. Avksentyev, M. V. Avksentyeva, E. V. Derkach, O. V. Platonova, A. V. Titkov, N. M. Kolyasnikova
"... ) are calculated in the probability model. Results. The total value of social and economic losses associated ..."
 
Vol 7, No 2 (2014) MANAGEMENT OF MAGNESIUM DEFICIENCY IN PREGNANT WOMEN: PHARMACOEPIDEMIOLOGIC STUDY Abstract  similar documents
D. V. Blinov, U. V. Zimovina, E. M. Dzhobava
"... ). Дефицит магния в связи с другими причинами являлся критерием исключения. Сбор данных проводился в течение ..."
 
Vol 5, No 1 (2012) PHARMACOECONOMIC EVALUATION OF THE PROPHYLAXIS OF POSTSURGICAL INFECTIOUS INFLAMMATORY COMPLICATIONS OF COMBINED ANTIBIOTIC DRUGS AND CORTICOSTEROIDS IN OPHTHALMIC PRACTICE IN RUSSIAN FEDERATION Abstract  similar documents
V. G. Serpik, R. I. Yagudina
"... , by the reason of lower value of cost-efficacy ratio, that was expressed at the cost of achieving of inflammatory ..."
 
Vol 6, No 4 (2013) Pharmacoeconomical assessment of сerebrolysin in the treatment of the acute disturbances of cerebral circulation Abstract  similar documents
A. Yu. Kulikov, L. A. Komarov
"... » с использованием в качестве критерия эффективности данных о ненаступлении ин валидности терапия ..."
 
Vol 7, No 4 (2014) APPLICATION OF MULTIPLE-CRITERIA ANALYSIS FOR OPTIMIZATION OF FINANCING OF RARE DISEASES Abstract  similar documents
V. V. Omelyanovskiy, V. K. Fedyaeva, O. Yu. Rebrova
"... основе множества критериев является комплексность принимаемых решений: данный вид анализа может ..."
 
Vol 11, No 4 (2018) “Near miss” in obstetrics: classification, evaluation, and significance for healthcare technology assessment Abstract  similar documents
I. K. Мamontova, T. V. Shevlyakovа, E. I. Petrova
"... ». Критерии состояния «near miss» впервые были определены в2009 г. В обзорной статье обоснована необходимость ..."
 
Vol 13, No 2 (2020) Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871 Abstract  similar documents
V. V. Omelyanovskiy, E. A. Maksimkina, O. I. Ivakhnenko, M. V. Avxentyeva, M. V. Sura, G. R. Khachatryan
"... , эволюция критериев, используемых при оценке; проведен анализ изменений, затронувших как порядок, так и ..."
 
Vol 5, No 3 (2012) PHARMACOECONOMIC EVALUATION OF TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON DIALYSIS WITH CINACALCET Abstract  similar documents
R. I. Yagudina, V. G. Serpik
"... % of patients reaching the target values of K / DOQI of the main biochemical parameters - parathyroid hormone ..."
 
Vol 9, No 3 (2016) METHOD «COST-EFFECTIVENESS» IN EVALUETION OF ATIBIOTIC TREATMENT OF ACYTR OBSTRUCTIVE BRONCHITIS IN CHILDREN IN HOSPITAL Abstract  similar documents
O. V. Zhukova, S. V. Kononova
"... ’s course of therapy characterized by a lower value CER in comparison with Amoxiklav. From ..."
 
Vol 8, No 2 (2015) SYSTEMATIC LITERATURE REVIEW ON CLINICAL EFFICACY AND SAFETY OF ALOGLIPTIN IN COMPARISON WITH VILDAGLIPTIN, LINAGLIPTIN, SAXAGLIPTIN AND SITAGLIPTIN IN ADULT PATIENTS WITH TYPE 2 DIABETES MELLITUS Abstract  similar documents
Georgii Rubenovich Khachatryan, Vladislav Sergeevich Dombrovskii
"... сочетании с метформином в сравнении с саксаглиптином в соче- тании с метформином при СД2Т по критерию ..."
 
Vol 10, No 3 (2017) ABC-analysis of pharmacotherapy in children hospitalized with bronchial asthma exacerbations Abstract  similar documents
O. V. Zhukova, S. V. Kononova
"... согласно выбранным критериям препараты систематизировались на три класса (А, В и С). В представленном ..."
 
Vol 5, No 3 (2012) PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH FIX COMBINATION OF CARBONIC ANHYDRASE INHIBITORS AND BETABLOCKERS Abstract  similar documents
M. V. Protsenko
"... , because of Azarga incremental cost-utility ratio is lower than willingness-to-pay threshold value ..."
 
Vol 8, No 1 (2015) PHARMACOEPIDEMIOLOGICAL EVALUATION OF HEPATOTROPIC THERAPY IN REAL CLINICAL PRACTICE Abstract  similar documents
D. V. Blinov, U. V. Zimovina, T. I. Ushakova
"... and methods. 2450 patients were included in 98 sites. Non-interventional on therapeutic strategy study ..."
 
Vol 8, No 2 (2015) PHARMACOECONOMIC STUDIES TREATMENT OF PATIENTS WITH INJURIES IN THE DEPARTMENT OF ANESTHESIOLOGY AND RESUSCITATION WITH METHODS ANALYSIS THE COST OF ILLNESS Abstract  similar documents
Anton Alexandrovich Kasatkin
"... ., and in the treatment of patients with blood loss of I degree – 7200 rubles. Conclusion. The value of direct medical ..."
 
Vol 12, No 2 (2019) Health technology assessment and reimbursement of pharmaceuticals in Italy Abstract  similar documents
F. V. Gorkavenko, V. V. Omelyanovskiy, T. P. Bezdenezhnykh, G. R. Khachatryan
"... required for providing value-based healthcare. Although the cost-effectiveness of specific health ..."
 
Vol 6, No 3 (2013) COST-UTILITY ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS Abstract  similar documents
R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov
"... эффективности, в качестве критериев эффективности были использованы значения добавленных лет жизни (LYG) и ..."
 
Vol 7, No 3 (2014) THE ANALYSIS OF METHODOLOGIC CHARACTERISTICS OF RESEARCHES ON SOCIAL AND ECONOMIC BURDEN OF DISEASES IN RUSSIA IN THE FRAMES OF DEVELOPMENT OF STANDARD COST OF ILLNESS METHODOLOGY FOR THE HEALTH TECHNOLOGY ASSESSMENT Abstract  similar documents
V. I. Ignatyeva, M. V. Avxentyeva
"... литературе был сформирован перечень критериев для анализа методических особенностей данного вида исследований ..."
 
1 - 50 of 84 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)